Price target
90.540.000.00%
The 13 analysts offering 1 year price forecasts for KROS have a max estimate of — and a min estimate of —.
Analyst rating
Based on 15 analysts giving stock ratings to KROS in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
KROS EPS for the last quarter is −1.41 USD despite the estimation of −1.28 USD. In the next quarter EPS is expected to reach −1.41 USD. Track more of Keros Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Keros Therapeutics, Inc. revenue is expected to reach 46.15 K USD. Check out Keros Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, KROS price target is 90.54 USD with a max estimate of 107.00 USD and a min estimate of 76.00 USD. Check if this forecast comes true in a year, meanwhile watch Keros Therapeutics, Inc. stock price chart and keep track of the current situation with KROS news and stock market news.
We've gathered opinions of 15 analysts rating KROS stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.